Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers

Background: Urinary tract infections (UTIs) are among the most common bacterial infections, with Escherichia coli (E. coli) being the leading causative agent. The increasing resistance of E. coli to commonly used antibiotics, including β-lactam antibiotics, poses a significant clinical challenge. U...

Full description

Saved in:
Bibliographic Details
Main Author: Shler Ali Khorsheed
Format: Article
Language:English
Published: Medsci Publications 2025-04-01
Series:National Journal of Medical Research
Subjects:
Online Access:https://njmr.in/index.php/file/article/view/1087
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761059422863360
author Shler Ali Khorsheed
author_facet Shler Ali Khorsheed
author_sort Shler Ali Khorsheed
collection DOAJ
description Background: Urinary tract infections (UTIs) are among the most common bacterial infections, with Escherichia coli (E. coli) being the leading causative agent. The increasing resistance of E. coli to commonly used antibiotics, including β-lactam antibiotics, poses a significant clinical challenge. Understanding antimicrobial resistance patterns and genetic diversity among E. coli isolates is essential for effective treatment and infection control. This study aimed to determine the prevalence of E. coli in UTI cases, assess its resistance to multiple antibiotics, evaluate β-lactamase and extended-spectrum beta-lactamase (ESBL) production, and analyze genetic diversity using molecular techniques. Materials and Methods: A total of 105 urine samples were collected from UTI patients at Rezali Hospital and General Hospital in Erbil (January–June 2024). Disk diffusion was used for antibiotic susceptibility testing, while MIC values were determined for penicillin and cephalosporin. β-lactamase production was assessed using the iodine titration method, ESBLs were confirmed using a disk proximity test, and RAPD markers were used for genetic diversity. Results: E. coli accounted for 48.51% of UTIs, showing high resistance to tetracycline (75.71%) and ceftriaxone (95.14%), and complete resistance to ampicillin and amoxicillin. β-lactamase production was detected in 84.62% of isolates, while 5.77% were ESBL producers. Genetic analysis indicated strain diversity, suggesting multiple nosocomial sources. Conclusion: The study highlights multidrug-resistant E. coli in UTIs, emphasizing the need for continuous surveillance and antibiotic stewardship programs to prevent treatment failures.
format Article
id doaj-art-b57b4d82f95b48fcbb10da64e8620e44
institution DOAJ
issn 2249-4995
2277-8810
language English
publishDate 2025-04-01
publisher Medsci Publications
record_format Article
series National Journal of Medical Research
spelling doaj-art-b57b4d82f95b48fcbb10da64e8620e442025-08-20T03:06:09ZengMedsci PublicationsNational Journal of Medical Research2249-49952277-88102025-04-01150210.55489/njmr.150220251087Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic MarkersShler Ali Khorsheed0Ministry Of Education, Open Educational College, Department of Biology, Kirkuk, Iraq Background: Urinary tract infections (UTIs) are among the most common bacterial infections, with Escherichia coli (E. coli) being the leading causative agent. The increasing resistance of E. coli to commonly used antibiotics, including β-lactam antibiotics, poses a significant clinical challenge. Understanding antimicrobial resistance patterns and genetic diversity among E. coli isolates is essential for effective treatment and infection control. This study aimed to determine the prevalence of E. coli in UTI cases, assess its resistance to multiple antibiotics, evaluate β-lactamase and extended-spectrum beta-lactamase (ESBL) production, and analyze genetic diversity using molecular techniques. Materials and Methods: A total of 105 urine samples were collected from UTI patients at Rezali Hospital and General Hospital in Erbil (January–June 2024). Disk diffusion was used for antibiotic susceptibility testing, while MIC values were determined for penicillin and cephalosporin. β-lactamase production was assessed using the iodine titration method, ESBLs were confirmed using a disk proximity test, and RAPD markers were used for genetic diversity. Results: E. coli accounted for 48.51% of UTIs, showing high resistance to tetracycline (75.71%) and ceftriaxone (95.14%), and complete resistance to ampicillin and amoxicillin. β-lactamase production was detected in 84.62% of isolates, while 5.77% were ESBL producers. Genetic analysis indicated strain diversity, suggesting multiple nosocomial sources. Conclusion: The study highlights multidrug-resistant E. coli in UTIs, emphasizing the need for continuous surveillance and antibiotic stewardship programs to prevent treatment failures. https://njmr.in/index.php/file/article/view/1087E. coliUTI infectionDNA polymerase chain reaction
spellingShingle Shler Ali Khorsheed
Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers
National Journal of Medical Research
E. coli
UTI infection
DNA polymerase chain reaction
title Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers
title_full Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers
title_fullStr Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers
title_full_unstemmed Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers
title_short Nosocomial E. Coli Isolated from UTI Identified Using DNA Markers Based on PCR and Pathogenic Markers
title_sort nosocomial e coli isolated from uti identified using dna markers based on pcr and pathogenic markers
topic E. coli
UTI infection
DNA polymerase chain reaction
url https://njmr.in/index.php/file/article/view/1087
work_keys_str_mv AT shleralikhorsheed nosocomialecoliisolatedfromutiidentifiedusingdnamarkersbasedonpcrandpathogenicmarkers